TNFRSF8 and lymphoma: This may be due to differences in affinity or concentration or the fact that CD30-GST was the exact immunogen used for development of our mAbs whereas AC10 was raised by immunization of mice with YT cells (a CD30+ lymphoma cell line) (31).